Meeting
2024 ASCO Genitourinary Cancers Symposium
Case Presentation
Presenter
Mehmet Asim Bilen, MD
Winship Cancer Institute of Emory University
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
General Session
Session Title
Management of Renal Cell Carcinoma With Sarcomatoid Features or Variant Histologies
Track
Renal Cell Cancer
Similar Videos & Slides
Videos & Slides
2012 ASCO Annual Meeting
Randomized phase II trial of cisplatin and radiotherapy with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Speaker: Renato Martins, MD, MPH
Videos & Slides
2012 ASCO Annual Meeting
Expression of p16, ERCC,1 and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, and erlotinib: A phase II randomized trial.
Speaker: Melissa Austin
Videos & Slides
2024 ASCO Annual Meeting
Long term results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
Speaker: Vijay Maruti Patil, MD, MBBS
Videos & Slides
2022 ASCO Annual Meeting
A randomized phase II study evaluating concurrent or sequential fixed-dose immune therapy in combination with cisplatin and intensity-modulated radiotherapy in intermediate- or high-risk, previously untreated, locally advanced head and neck cancer (LA SCCHN).
Speaker: David Anthony Clump, MD